SV2 modulates the size of the readily releasable pool of secretory vesicles
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
The exocytosis of neurotransmitters is regulated by calcium and is plastic - features that suggest specialized regulation of the basic membrane trafficking process. Here we show that Synaptic Vesicle Protein 2 (SV2), a protein specific to neurons and endocrine cells, is required to maintain a pool of vesicles available for calcium-stimulated exocytosis. Direct measures of exocytosis in adrenal chromaffin cells showed that the calcium-induced exocytotic burst, which operationally defines the readily releasable pool of vesicles, was significantly reduced in mice lacking SV2A. Burst kinetics were normal in cells from SV2A knockout animals, however, indicating that SV2 functions before the final events of fusion. Analyses of SDS-resistant SNARE (soluble NSF (N-ethylmaleimide-sensitive fusion) attachment protein receptor) complexes in brain tissue showed that loss of SV2A was associated with fewer SDS-resistant complexes. Our observations indicate that SV2 may modulate the formation of protein complexes required for fusion and therefore the progression of vesicles to a fusion-competent state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SV2A is a core presynaptic regulator that coordinates vesicle priming, calcium dependent release, and neurotransmitter loading to ensure reliable synaptic transmission [184,185,186].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [185]
In the citing paper
“SV2A also stabilizes vesicle content and maintains the readily releasable pool, thereby tuning short term plasticity and sustaining output during repeated activity [185,186,194].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [185]
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
(1995) · Springer eBooks · doi:10.1007/978-1-4419-1229-9 · Cited by 2,526
SNAREpins: Minimal Machinery for Membrane Fusion
Weber, T., Zemelman, B. V., McNew, J. A., Westermann, B., Gmachl, M., Parlati, F., Söllner, T. H., & Rothman, J. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81404-x · Cited by 2,475
Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution
Sutton, R. B., Fasshauer, D., Jahn, R., & Brunger, A. T. (1998) · Nature · doi:10.1038/26412 · Cited by 2,417
Synaptotagmin I: A major Ca2+ sensor for transmitter release at a central synapse
Geppert, M., Goda, Y., Hammer, R. E., Li, C., Rosahl, T. W., Stevens, C. F., & Südhof, T. C. (1994) · Cell · doi:10.1016/0092-8674(94)90556-8 · Cited by 1,483
Gene expression profile of aging and its retardation by caloric restriction
Lee, C.-K., Klopp, R. G., Weindruch, R., & Prolla, T. A. (1999) · Science · doi:10.1126/science.285.5432.1390 · Cited by 1,473 · cited 1×
“Interestingly, the expression of SV2 changes with agein”
BackgroundMembrane Fusion and Exocytosis
Jahn, R., & Südhof, T. C. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.863 · Cited by 1,259
Heterogeneity of release probability, facilitation, and depletion at central synapses
Dobrunz, L. E., & Stevens, C. F. (1997) · Neuron · doi:10.1016/s0896-6273(00)80338-4 · Cited by 1,183
(1995) · Springer eBooks · doi:10.1007/978-1-4615-7858-1 · Cited by 1,039
Neher, E., & Marty, A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.21.6712 · Cited by 1,006
Cited by
Items 101–200 of 211
Targeting SV2A for discovery of antiepileptic drugs
Kaminski, R. M., Gillard, M., & Klitgaard, H. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02869.x · Cited by 33
Visualization of SV2A conformations in situ by the use of Protein Tomography
Lynch, B. A., Matagne, A., Brännström, A., von Euler, A., Jansson, M., Hauzenberger, E., & Söderhäll, J. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.145 · Cited by 37
Targeting SV2A for Discovery of Antiepileptic Drugs
Kaminski, R. M., Gillard, M., & Klitgaard, H. (2012) · Jasper's Basic Mechanisms of the Epilepsies · doi:10.1093/med/9780199746545.003.0076 · Cited by 31
Tokudome, K., Okumura, T., Terada, R., Shimizu, S., Kunisawa, N., Mashimo, T., Serikawa, T., Sasa, M., & Ohno, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00210 · Cited by 31
Miquel-Rio, L., Sarriés-Serrano, U., Pavia-Collado, R., Meana, J. J., & Bortolozzi, A. A. (2023) · Biomedicines · doi:10.3390/biomedicines11020541 · Cited by 34
Lee, J., Daniels, V., Sands, Z. A., Lebon, F., Shi, J., & Biggin, P. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116589 · Cited by 29
Okada, M., Fukuyama, K., Shiroyama, T., & Ueda, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111462 · Cited by 28
Daniels, V, Wood, M., Leclercq, K., Kaminski, R. M., & Gillard, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12192 · Cited by 28
Abdulfatai, U., Uzairu, A., & Uba, S. (2017) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1016/j.bjbas.2017.11.002 · Cited by 29
Melrose, J. (2019) · Advanced Biosystems · doi:10.1002/adbi.201800327 · Cited by 26
Kindling-associated SV2A expression in hilar GABAergic interneurons of the mouse dentate gyrus
Ohno, Y., Okumura, T., Terada, R., Ishihara, S., Serikawa, T., & Sasa, M. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.01.009 · Cited by 26
Anti‐ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats
Dupuis, N., Matagne, A., Staelens, L., Dournaud, P., Desnous, B., Gressèns, P., & Auvin, S. (2015) · Epilepsia · doi:10.1111/epi.12973 · Cited by 25
Perri, E. R., Parakh, S., & Atkin, J. D. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1254197 · Cited by 27
Xiong, M., Roshanbin, S., Rokka, J., Schlein, E., Ingelsson, M., Sehlin, D., Eriksson, J., & Syvänen, S. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118302 · Cited by 24
“Because SV2A may function before the final fusion of vesicles, the changes in synaptic strength and altered presynaptic Ca 2+ attributed to SV2 loss can occur at different time points during disease progression ( Wan et al., 2010 ; Xu and Bajjalieh, 2001 ).”
The neural milieu of the developing choroid plexus: neural stem cells, neurons and innervation
Prasongchean, W., Vernay, B., Asgarian, Z., Jannatul, N., & Ferretti, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00103 · Cited by 23
Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain
Dunn, A. R., Hoffman, C. A., Stout, K. A., Ozawa, M., Dhamsania, R. K., & Miller, G. W. (2017) · Brain Research · doi:10.1016/j.brainres.2017.12.029 · Cited by 25
APP Is a Context-Sensitive Regulator of the Hippocampal Presynaptic Active Zone
Laßek, M., Weingarten, J., Wegner, M., Mueller, B. F., Rohmer, M., Baeumlisberger, D., Arrey, T. N., Hick, M., Ackermann, J., Acker‐Palmer, A., et al. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004832 · Cited by 24
Kwan, P., Lim, S. H., Chinvarun, Y., Cabral‐Lim, L., Aziz, Z. A., Lo, Y., Tonner, F., Beh, K. M. K., & Edrich, P. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.03.016 · Cited by 26
Accumulation of 7S SNARE complexes in hippocampal synaptosomes from chronically kindled rats
Matveeva, E. A., Whiteheart, S. W., & Slevin, J. T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01589.x · Cited by 23
Levetiracetam-induced a new seizure type in a girl with a novel SV2A gene mutation
Wang, D., Zhou, Q., Ren, L., Lin, Y., Gao, L., Du, J., & Wang, Y. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.03.020 · Cited by 25
The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy
Russo, E., Citraro, R., & Mula, M. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1366985 · Cited by 21
Heese, K., Nagai, Y., & Sawada, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5932 · Cited by 21
Antiepileptic drug discovery: lessons from the past and future challenges
Klitgaard, H. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00513.x · Cited by 26
Engel, A. (2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)01503-5 · Cited by 54
Calame, D. G., Herman, I., & Riviello, J. J. (2021) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2020.100425 · Cited by 25
Lima, R., Gomes, E. D., Cibrão, J. R., Rocha, L. A., Assunção-Silva, R. C., Rodrigues, C. S., Neves‐Carvalho, A., Monteiro, S., Salgado, A. J., & Silva, N. A. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00121-7 · Cited by 20
SVOP Is a Nucleotide Binding Protein
Yao, J., & Bajjalieh, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005315 · Cited by 22
Self-citationFronczak, K. M., Li, Y., Henchir, J., Dixon, C. E., & Carlson, S. W. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02534-3 · Cited by 18
Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias
Cerri, S., Siani, F., & Blandini, F. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1333598 · Cited by 19
Contreras-García, I. J., Pichardo-Macías, L. A., Santana-Gómez, C. E., Sánchez-Huerta, K., Ramírez-Hernández, R., Gómez-González, B., Rocha, L., & Mendoza Torreblanca, J. G. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.08.023 · Cited by 18
Evolution of insect proteomes: insights into synapse organization and synaptic vesicle life cycle
Yanay, C., Morpurgo, N., & Linial, M. (2008) · Genome biology · doi:10.1186/gb-2008-9-2-r27 · Cited by 20
Novel congenital myasthenic syndromes associated with defects in quantal release
Milone, M., Fukuda, T., Shen, X., Tsujino, A., Brengman, J. M., & Engel, A. G. (2006) · Neurology · doi:10.1212/01.wnl.0000205596.19540.2c · Cited by 17
Rapid kindling in preclinical anti-epileptic drug development: The effect of levetiracetam
Smedt, T. D., Vonck, K. E. J., Raedt, R., Dedeurwaerdere, S., Claeys, P., Legros, B., Wyckhuys, T., Wadman, W. J., & Boon, P. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.09.004 · Cited by 18
Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients
Somerville, E. R., McLaughlin, D. B., Robinson, M. K., & Berkovic, S. F. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.06.005 · Cited by 18
López-Manzaneda, M., Franco-Espín, J., Tejero, R., Cano, R., & Tabares, L. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab065 · Cited by 16
Zhang, Y., Heylen, L., Partoens, M., Mills, J. D., Kaminski, R. M., Godard, P., Gillard, M. R., de Witte, P. A. M., & Siekierska, A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.881933 · Cited by 16
Efferent innervation to the auditory basilar papilla of scincid lizards
Wibowo, E., Brockhausen, J., & Köppl, C. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22101 · Cited by 14
Martín, A. G., Sopelana‐Garay, D., Pardal-Fernández, J. M., Sánchez‐Honrubia, R. M., & Sánchez‐Larsen, Á. (2018) · Epileptic Disorders · doi:10.1684/epd.2017.0939 · Cited by 13
Botermans, W., Koole, M. J. B., Laere, K. V., Savidge, J. R., Kemp, J. A., Sunaert, S. G., Duffy, M. M., Ramael, S., Cesura, A. M., D’Ostilio, K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1066447 · Cited by 16
Liu, H., Hu, Z., Zhou, K., Jiu, Y., Yang, H., Wu, Z., & Xu, T. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20598 · Cited by 13
Self-citationBehavioural phenotyping reveals anxiety-like features of SV2A deficient mice
Lamberty, Y., Detrait, E., Leclercq, K., Michel, A., & Ryck, M. D. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.005 · Cited by 13
SV2 frustrating exocytosis at the semi‐diffusor synapse
Vautrin, J. (2009) · Synapse · doi:10.1002/syn.20610 · Cited by 12
SV2B defines a subpopulation of synaptic vesicles
Paulußen, I., Beckert, H., Musial, T. F., Gschossmann, L. J., Wolf, J., Schmitt, M., Clasadonte, J., Mairet‐Coello, G., Wolff, C., Schoch, S., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad054 · Cited by 14
Harada, S., Tanaka, S., Takahashi, Y., Matsumura, H., Shimamoto, C., Nakano, T., Kuwabara, H., Sawabe, Y., & Nakahari, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.037 · Cited by 11
Pichardo‐Macías, L. A., Contreras‐García, I. J., Zamudio, S., Mixcoha, E., & Mendoza‐Torreblanca, J. G. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-6355-3_4 · Cited by 12
Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats
Shi, J., Zhou, F., Wang, L., & Wu, G. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1496-0 · Cited by 10
Zagaja, M. P., Haratym-Maj, A., Szewczyk, A., Rola, R., Maj, M., Łuszczki, J. J., & Andres‐Mach, M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.016 · Cited by 10
Jupp, B., Pitzoi, S., Petretto, E. G., Mar, A. C., Peña‐Oliver, Y., Jordan, E. R., Taylor, S., Atanur, S. S., Srivastava, P. K., Saar, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63646-9 · Cited by 10
Synaptic vesicle 2C and its synaptic-related function
Hu, Y., Xiao, L., Zheng, L., & Wang, Q. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.07.029 · Cited by 10
Kriechbaumer, S. R. P., Jurina, K., Wielaender, F., Schenk, H. C., Steinberg, T. A., Reese, S., Buhmann, G., Dörfelt, S., Potschka, H., & Fischer, A. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.910038 · Cited by 13
Loss of the SV2-like Protein SVOP Produces No Apparent Deficits in Laboratory Mice
Yao, J., de la Iglesia, H. O., & Bajjalieh, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068215 · Cited by 12
Self-citationLambeng, N., Grossmann, M., Chatelain, P., & Fuks, B. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.059 · Cited by 11
Frycia, A., Starck, J., Jadot, S., Lallemand, B., Leclercq, K., Brutto, P. L., Matagne, A., Verbois, V., Mercier, J., & Kenda, B. (2009) · ChemMedChem · doi:10.1002/cmdc.200900436 · Cited by 8
Ma, Y., Gao, K., Sun, X., Wang, J., Yang, Y., Wu, J., Chai, A., Li, Y., Liu, N., Yu, H., et al. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.02.013 · Cited by 10
SNARE Protein Recycling by αSNAP and βSNAP Supports Synaptic Vesicle Priming
Burgalossi, A., Jung, S., Meyer, G., Jockusch, W. J., Jahn, O., Taschenberger, H., O'Connor, V. M., Nishiki, T., Takahashi, M., Brose, N., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.01.015 · Cited by 8
Pharmacotherapy of idiopathic generalized epilepsies
Curatolo, P., Moavero, R., Castro, A. L., & Cerminara, C. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802618647 · Cited by 8
Probing Rotational Viscosity in Synaptic Vesicles
Zeigler, M. B., Allen, P. B., & Chiu, D. T. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.04.042 · Cited by 9
Everett, A. W., Edwards, S. J., & Etherington, S. J. (2002) · Journal of Neurocytology · doi:10.1023/a:1022515430224 · Cited by 5
Hogg, J. A., & Cousin, M. A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16308 · Cited by 5
Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy
Tokudome, K., Shimizu, S., Serikawa, T., & Ohno, Y. (2018) · Folia Pharmacologica Japonica · doi:10.1254/fpj.152.275 · Cited by 7
Ignacio‐Mejía, I., Contreras‐García, I. J., Pichardo‐Macías, L. A., García‐Cruz, M. E., Ramírez‐Mendiola, B., Bandala, C., Medina‐Campos, O. N., Pedraza‐Chaverrí, J., Cárdenas‐Rodríguez, N., & Mendoza‐Torreblanca, J. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179313 · Cited by 4
Kunze, L. H., Palumbo, G., Gnörich, J. S., Wind-Mark, K., Schaefer, R., Lindner, S., Gildehaus, F. J., Ziegler, S., & Brendel, M. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121165 · Cited by 6
Synaptic vesicle protein 2b is expressed temporospatially in (pre)odontoblasts in developing molars
Yang, S., Jeon, S., Kang, J., Yoo, H., Kim, Y., Moon, J., Kim, M., Koh, J., Oh, W., & Kim, S. (2012) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2012.01001.x · Cited by 4
Molecular docking and QSAR analysis of a few Gama amino butyric acid aminotransferase inhibitors
Abdulfatai, U., Uzairu, A., & Uba, S. (2018) · Egyptian Journal of Basic and Applied Sciences · doi:10.1016/j.ejbas.2018.01.003 · Cited by 4
Grabs, D., Escher, L., & Bergmann, M. (2008) · The Anatomical Record · doi:10.1002/ar.20691 · Cited by 4
Levetiracetam inhibits SV2A-synaptotagmin interaction at synapses that lack SV2BPreprint
Ciruelas, K., Marcotulli, D., Sullivan, J., & Bajjalieh, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/640185 · Cited by 4
Self-citationLevetiracetam: An antiseizure drug with unique neuroprotective properties
Ewens, A. N., & Thayer, S. A. (2025) · ASPET Discovery · doi:10.1016/j.aspetd.2025.100006 · Cited by 5
Sawhney, S. K., Narayan, C., Mishra, A., Singh, M., & Kaur, A. P. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00053 · Cited by 3
Characteristics of selected second-generation antiepileptic drugs used in dogs
Ziółkowski, H., JAROSZEWSKI, J. J., Ziółkowska, N., & Jasiecka-Mikołajczyk, A. (2012) · Polish Journal of Veterinary Sciences · doi:10.2478/v10181-012-0088-1 · Cited by 3
Walmsley, S. J., & Gaines, P. J. (2004) · Insect Molecular Biology · doi:10.1111/j.0962-1075.2004.00478.x · Cited by 3
SV2A: More than Just a New Target for AEDs
Pitkänen, A. (2005) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7597.2005.05104.x · Cited by 3
Increased neurogenesis after ACEA and levetiracetam treatment in mouse pilocarpine model of epilepsy
Zagaja, M. P., Szewczyk, A., Haratym-Maj, A., Rola, R., Maj, M., Łuszczki, J. J., & Andres‐Mach, M. (2017) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/81283 · Cited by 3
Developmental analysis of SV2 in the embryonic chicken corneal epithelium
Talbot, C. J., & Kubilus, J. K. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.04.002 · Cited by 3
Hu, Z., Zhao, P., Liu, J., Wu, Z.-X., & Xu, T. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00129.x · Cited by 3
Self-citationD’Souza, J., & Perucca, E. (2015) · doi:10.1002/9781118936979.ch31 · Cited by 3
Wu, Z., Zhao, Y., Zhang, X., & Li, Y. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2468351 · Cited by 3
Computational Analyses of the Mechanism of Action of Antiepileptic Agents
Sinha, S., Dubey, M., Misal, S., Alavala, R. R., & Ramaa, C. S. (2025) · Springer eBooks · doi:10.1007/978-981-96-4154-3_24 · Cited by 3
Recent Advances and Future Directions in the Treatment of Epilepsy
Kurokawa, T., Kazuta, Y., & Watanabe, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12436-9 · Cited by 2
Huang, J., Yan, R., Shi, H., Wang, P., & He, J. (2014) · Asia-Pacific Journal of Chemical Engineering · doi:10.1002/apj.1848 · Cited by 2
Wang, L., Xin Min, Z. H. O. U., Shi, J., Wu, G., & Hong, Z. Y. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000383 · Cited by 2
Nagarajan, N., Custer, K. L., & Bajjalieh, S. (2009) · Springer eBooks · doi:10.1007/978-0-387-93877-6_5 · Cited by 2
Self-citationLang, J., Linnerbauer, M., Cuny, J., Rothhammer, V., & Hamer, H. (2026) · Epilepsia · doi:10.1002/epi.70122 · Cited by 1
Synaptic Vesicle Glycoprotein 2A and Epilepsy
Hanaya, R., Hosoyama, H., & Arita, K. (2018) · てんかん研究 · doi:10.3805/jjes.36.3 · Cited by 1
Investigation Of The Molecular Mechanisms Of Synaptic Tagging And Capture
Park, J. W. (2014) · Scholarly Commons (University of Pennsylvania) · Cited by 1
Maturation and heterogeneity of vertebrate motor synapses
Tejero, R., López-Manzaneda, M., Franco-Espín, J., & Tabares, L. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.02.009 · Cited by 1
Effect of antiepileptic drug levetiracetam on cochlear function
Li, L., Chen, G., & Salvi, R. (2021) · Hearing Research · doi:10.1016/j.heares.2021.108396 · Cited by 1
Mechanisms of Antiepileptic Drug Action
Simeone, T. A. (2010) · Epilepsy · doi:10.1201/9781420085594-c8 · Cited by 5
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Transgenic Mouse Models in the Analysis of Neurotransmitter Release Mechanisms
Brose, N., & Rettig, J. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18934-0_8
The Role of alpha- and beta-SNAP in Synaptic Vesicle Exocytosis
Burgalossi, A. (2008) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3167
Identification of Genes in the Dorsal Raphe Nucleus Regulated by Chronic Stress and Citalopram
Abumaria, N. (2006) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3175
Raghunath, A. (2009) · Dublin City University Open Access Institutional Repository (Dublin City University)
Meehan, A. L. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
The role of α- and β-SNAP in synaptic vesicle exocytosis
Burgalossi, A. (2008) · MPG.PuRe (Max Planck Society)
The Effect of Nitrendipine and Levetiracetam in Pentylenetetrazole Kindled Rats
(2019) · International Journal of Neuroscience Research · doi:10.28933/ijnr-2019-05-1306
Evidence for Synaptic Vesicle Binding by the C-terminal of a Short Splice CaV2.1 Calcium Channel
Snidal, C. A. (2018) · TSpace (University of Toronto)
Lost in Space: How a Single, Directionless Protein Can Cause So Much Mayhem
Salvati, K. A., & Beenhakker, M. P. (2020) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759720955169
Li, L. (2005) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1423
Metadata
- Authors
- Xu, T., & Bajjalieh, S. M.
- Affiliations
- University of Washington (US)
- Corresponding author
- Bajjalieh, Sandra M.
- ORCID
- Xu, Tao
- Venue
- Nature Cell Biology
- Published
- 2001-07-06
- Volume
- 3
- Issue
- 8
- Pages
- 691-698
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W1498064496
- Cited by
- 212
- References
- 54
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 10 · 2017: 9 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 8 · 2012: 12
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- synaptic vesicle protein 2, SV2A, readily releasable pool, secretory vesicles, neurotransmitter release, adrenal chromaffin cells, SNARE complex, vesicle fusion, membrane trafficking, knockout mice
- MeSH terms
- Adrenal Medulla, Animals, Cell Count, Exocytosis, Membrane Glycoproteins, Membrane Proteins, Microscopy, Electron, Nerve Tissue Proteins, Nervous System, Synaptic Membranes, Presynaptic Terminals, Mice, Knockout, Neurotransmitter Agents, Chromaffin Cells, Calcium Signaling, Protein Isoforms, Protein Transport, Secretory Vesicles, Vesicular Transport Proteins, SNARE Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.